Exercise Program for Chronic Obstructive Pulmonary Disease
Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Recruiting
N/A
Interventional Study
Chronic Obstructive Pulmonary Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 80 (estimated)
- Sponsor
- Uppsala University · Other
Who this trial is looking for
This trial is looking for people with Chronic Obstructive Pulmonary Disease (COPD) to take part in an exercise program. Participants will undergo assessments before and after the program to see how exercise might help improve lung function and quality of life.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with Chronic Obstructive Pulmonary Disease.
- My lung capacity is between 30% and 85% of what is normal.
- I am following my doctor's treatment plan for COPD.
- I have not smoked for at least one year.
- I have not had any COPD flare-ups in the last 4 weeks.
- My BMI is between 18 and 35.
- I do not have other serious health problems affecting my ability to exercise.
You may not be able to join if
- I regularly participate in special exercise sessions.
- I have unstable heart or lung disease.
- I currently smoke.
- My doctor thinks I should not take part in an exercise program.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identif…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator
* Optimal medical treatment according to GOLD and the Swedish National Guidelines
* Absence of other significant diseases that could contribute to physical exercise limitation
* Non-smoking …
Contacts
No contact information available.